Weighted Average Number of Shares Outstanding, Diluted of Inmune Bio, Inc. from Q3 2021 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Inmune Bio, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q3 2021 to Q3 2025.
- Inmune Bio, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 26.6M shares, a 31.7% increase year-over-year.
- Inmune Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 19.9M shares, a 10.9% increase from 2023.
- Inmune Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 18M shares, a 0.3% increase from 2022.
- Inmune Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17.9M shares, a 11.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)